Glaxosmithkline Pharmaceuticals Ltd. | GLAXO | NSE - Pharmaceuticals


INR in Million. Fiscal year ends in March. Figures are consolidated and restated..

Upgrade Membership to see 10 year accurate financial statements.

 Chart
2017
2018
2019
2020
2021
Revenue
Revenue
30,00028,95631,28132,24433,094
Cost of revenue
Cost of revenue
-13,977-12,655-13,580-13,079-13,127
Gross Profit
Gross Profit
16,022
16,301
17,701
19,165
19,967
Sales, general & ad...
Sales, general and administrative
-11,833-11,243-11,693-12,593-11,908
Depreciation
Depreciation and amortization
-263-380-486-827-793
Provision
Provision
00000
Other op inc/exp...
Other operating income/expenses
00000
Operating income
Operating income EBIT
3,926
4,678
5,522
5,746
7,266
 
      
Interest expense
Interest expense
0-2-6-63-35
Other income/exp...
Other income(expense)
1,1867231,310-2,625-1,726
Profit before tax
Profit before tax
5,112
5,400
6,827
3,058
5,505
Income tax & other ta...
Income tax and other taxes
1,7441,8922,3732,1251,924
Net income from c...
Net income from continuing operations
3,3683,5074,4549323,581
Extraordinary & disc...
Extraordinary items & Discontinued Ops
00000
Share of associates
Share of associates
00000
Minority Interest
Minority Interest
00000
Net Income
Net income
3,368
3,507
4,454
932
3,581
 
      
NI - Preferred Di...
Net Income after Preferred Dividend and Others
3,3683,5074,4549323,581
Basic shares
Basic shares
169169169169169
Diluted Shares
Diluted Shares
169169169169169
EPS Basic
EPS Basic in Rupees
19.8820.7026.295.5021.14
EPS Diluted
EPS Diluted in Rupees
19.88
20.70
26.29
5.50
21.14